Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Efficacy and safety of pimavanserin in patients with Alzheimer's dementia psychosis in the HARMONY phase 3, randomized discontinuation study: a post hoc subgroup analysis
Alzheimer's & Dementia · Vol. 18 Published January 1, 2022
More on these topics
Browse all publications →-
2026 · Nat Med
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease
-
2025 · Neurotherapeutics
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
-
2025 · J Prev Alzheimers Dis
Donanemab: Appropriate use recommendations
-
2024 · Alzheimer's Association International Conference (AAIC)
Navigating the Complexities of Alzheimer's Clinical Trials: The Perils of Small Molecule Studies and the Risk of Fraudulent Practices